December 2
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study in Patients Chronically Infected with Hepatitis C
December 1
NPS Pharmaceuticals Completes Submission of New Drug Application for GATTEX(R) (teduglutide) in Adult Short Bowel Syndrome (SBS)
Aegerion Pharmaceuticals to Participate in the 2011 Deutsche Bank BioFEST Conference
Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease
Cyclacel to Webcast Analyst & Institutional Investor Meeting Wednesday, December 7, 2011
Senesco Receives Milestone Payment from Bayer CropScience
CircuLite® Raises $30 Million Series D Financing
The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST
NPS Pharmaceuticals to Present at Deutsche Bank BioFEST Conference
Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
November 25
Celgene Corporation to Present at the Piper Jaffray Health Care Conference 2011
November 23
A Tribute to Alex Barkas
Advaxis Completes Pre-IND Meeting for ADXS-HER2
November 22
Lexicon Announces Commencement of Rights Offering to Stockholders
Senesco to Present at NYSSA’s 2011 Biotech / Specialty Pharma Conference
Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
Savara Inc. Joins SAFE-BioPharma Association
Hoping Pharmasset Gains Jobs After Being Sold to Calif. Biotech in $11B deal
November 17
Edge Therapeutics Appoints James J. Loughlin to Board of Directors
November 15
Immunomedics Awarded Additional U.S. Patent for Anti-Cd20 Treatment of Autoimmune Diseases
Bio-Reference Laboratories Named 8th Fastest Growing Company in State of New Jersey
Advaxis Licenses Novel Antigen for Severe Breast Cancer and Other Tumor Types
DuPont Crop Protection and BioLeap Enter Research Collaboration
Soligenix Reports Third Quarter 2011 Financial Results
Cyclacel Pharmaceuticals Reports Third Quarter 2011 Financial Results
Pharmasset Reports Fiscal Year End 2011 Financial Results
Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
November 12
Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
November 11
Derma Sciences Reports Third Quarter Financial and Operating Results; End-of-Phase 2 Meeting Set with FDA
Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz®(atazanavir sulfate) in Brazil
Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan
Lexicon Announces Plans for Rights Offering to Stockholders
November 10
CorMedix Reports Third Quarter 2011 Results